PR Newswire BOLINGBROOK, Ill., Oct. 3, 2024 Standfirst: Welllife, a Flu home test in addition to COVID-19 BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is ...
PR Newswire BALDWIN PARK, Calif., Oct. 3, 2024 BALDWIN PARK, Calif., Oct. 3, 2024 /PRNewswire/ -- StemCyte announced today that its Hematopoietic Progenitor Cell Cord Blood therapy (HPC Cord Blood) has officially obtained the Regenerative ...
PR Newswire ROCKVILLE, Md., Oct. 3, 2024 ROCKVILLE, Md., Oct. 3, 2024 /PRNewswire/ -- Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ...
PR Newswire WASHINGTON, Oct. 2, 2024 WASHINGTON, Oct. 2, 2024 /PRNewswire/ -- The U.S. Postal Service will again deliver millions of rapid at-home COVID-19 test kits to households across the nation. In collaboration with the White ...
PR Newswire WALTHAM, Mass. and SAN DIEGO, Sept. 30, 2024 Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results ...
PR Newswire TEL-AVIV, Israel and RALEIGH, N.C., Sept. 30, 2024 New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (=60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib ...
PR Newswire SAN DIEGO, Sept. 17, 2024 SAN DIEGO, Sept. 17, 2024 /PRNewswire/ -- Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an investigator-initiated trial to ...
PR Newswire PORTLAND, Ore., Sept. 17, 2024 First large-scale, in-depth analysis shows uneven recovery in science achievement across the elementary and middle grades PORTLAND, Ore., Sept. 17, 2024 /PRNewswire/ -- NWEA, a K-12 assessment ...
PR Newswire NEW HAVEN, Conn., Sept. 16, 2024 NEW HAVEN, Conn., Sept. 16, 2024 /PRNewswire/ -- Leaders from across Yale School of Medicine will present new strategies for improving health equity, developed during their response to the ...
PR Newswire HOUSTON, Sept. 16, 2024 KARE's Study Reveals How Work Culture Must Evolve to Retain Senior, Post-Acute Care Workers HOUSTON, Sept. 16, 2024 /PRNewswire-PRWeb/ -- KARE, the leading digital labor marketplace for post-acute and ...
Discover how COVID-19 vaccines reduce the risk of unexplained sudden death in young adults.
First-ever mouse strain CAST/EiJ mouse naturally susceptible to severe COVID-19 discovered, enabling advanced research without genetic modification.
How is long COVID derailing workdays? Long COVID symptoms keep workers away from their jobs, draining workdays and stalling productivity.
The latest COVID-19 treatment, using an inhibitor of the Fas ligand (FasL), also known as CD95 ligand (CD95L), speeds up recovery and reduces mortality.
The new AI tool provides personalized care for long COVID patients, aiming to reduce diagnostic biases and improve equity in treatment.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers